Your healthcare team can adjust your treatment plan, provide supportive management for side effects, or consider alternative therapies if GLP-1 receptor agonists are not suitable for you
In a post-hoc analysis of the REWIND trial, involving 9901 patients, Cukierman-Yaffe et al
Research due to be presented at the American Academy of Neurologys 77th Annual Meeting in early April 2025 and which is yet to undergo peer review has found that moderate-to-vigorous exercise is linked to a lower likelihood of developing a range of neuropsychiatric diseases, including dementia and depression
G9270, G9271, G9272 Caspase-Glo 3/7 Assay System An easy-to-use, plate-based luminescent assay for detecting caspase-3/7 activity
While some inflammation is necessary to initiate healing, chronic inflammation is destructive